1. Home
  2. GEL vs SNDX Comparison

GEL vs SNDX Comparison

Compare GEL & SNDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEL
  • SNDX
  • Stock Information
  • Founded
  • GEL 1996
  • SNDX 2005
  • Country
  • GEL United States
  • SNDX United States
  • Employees
  • GEL N/A
  • SNDX N/A
  • Industry
  • GEL Oil Refining/Marketing
  • SNDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEL Energy
  • SNDX Health Care
  • Exchange
  • GEL Nasdaq
  • SNDX Nasdaq
  • Market Cap
  • GEL 1.3B
  • SNDX 1.1B
  • IPO Year
  • GEL 1996
  • SNDX 2016
  • Fundamental
  • Price
  • GEL $10.47
  • SNDX $13.67
  • Analyst Decision
  • GEL Buy
  • SNDX Strong Buy
  • Analyst Count
  • GEL 2
  • SNDX 10
  • Target Price
  • GEL $16.00
  • SNDX $36.20
  • AVG Volume (30 Days)
  • GEL 482.2K
  • SNDX 2.6M
  • Earning Date
  • GEL 02-13-2025
  • SNDX 02-25-2025
  • Dividend Yield
  • GEL 6.29%
  • SNDX N/A
  • EPS Growth
  • GEL N/A
  • SNDX N/A
  • EPS
  • GEL N/A
  • SNDX N/A
  • Revenue
  • GEL $3,014,767,000.00
  • SNDX $16,000,000.00
  • Revenue This Year
  • GEL N/A
  • SNDX N/A
  • Revenue Next Year
  • GEL $0.97
  • SNDX N/A
  • P/E Ratio
  • GEL N/A
  • SNDX N/A
  • Revenue Growth
  • GEL N/A
  • SNDX N/A
  • 52 Week Low
  • GEL $9.86
  • SNDX $12.06
  • 52 Week High
  • GEL $15.17
  • SNDX $25.34
  • Technical
  • Relative Strength Index (RSI)
  • GEL 46.87
  • SNDX 48.26
  • Support Level
  • GEL $10.25
  • SNDX $12.40
  • Resistance Level
  • GEL $10.61
  • SNDX $13.16
  • Average True Range (ATR)
  • GEL 0.33
  • SNDX 0.66
  • MACD
  • GEL 0.09
  • SNDX 0.14
  • Stochastic Oscillator
  • GEL 53.16
  • SNDX 62.16

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a United States-based limited partnership that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

Share on Social Networks: